InvestorsHub Logo
Followers 1055
Posts 189434
Boards Moderated 1
Alias Born 06/19/2009

Re: ash111 post# 93292

Tuesday, 05/24/2016 8:13:13 AM

Tuesday, May 24, 2016 8:13:13 AM

Post# of 97237
ONGN .90 Pre market.OXiGENE Announces Results of Phase 2 Study of CA4P in Recurrent Ovarian Cancer Published in Journal of Clinical Oncology.
http://ih.advfn.com/p.php?pid=nmona&article=71559457

My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.